PCM
ASMB icon

Penserra Capital Management’s Assembly Biosciences ASMB Stock Holding History

Penserra Capital Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-86
Closed -$3K – 1375
2021
Q3 		$3K Buy
86
+10
+13% +$419 ﹤0.01% 1427
2021
Q2 		$3K Buy
76
+5
+7% +$248 ﹤0.01% 1326
2021
Q1 		$3K Buy
71
+8
+13% +$530 ﹤0.01% 1095
2020
Q4 		$4K Buy
63
+40
+174% +$4.69K ﹤0.01% 989
2020
Q3 		$4K Buy
+23
New +$5.79K ﹤0.01% 865

Other funds holding ASMB

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Penserra Capital Management's ASMB Position: Q4 2021 in Review

Penserra Capital Management sold out of Assembly Biosciences (ASMB) in Q4 2021, closing a stake of 86 shares — an estimated $3K sold.

Penserra Capital Management first reported a position in ASMB in Q3 2020 and held it in 5 quarters. The position peaked at $4K in Q4 2020. 62 funds tracked by Wall St. Rank hold ASMB as of Q4 2021.

  • Penserra Capital Management reported no remaining Assembly Biosciences position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 86 Assembly Biosciences shares in Q4 2021, an estimated $3K.
  • Penserra Capital Management first reported a position in Assembly Biosciences in Q3 2020 and held it in 5 quarters.
  • Penserra Capital Management's Assembly Biosciences position peaked at $4K in Q4 2020.
  • 62 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.